US2022273238A1PendingUtilityA1
Measurement of Edema
Est. expiryFeb 3, 2037(~10.5 yrs left)· nominal 20-yr term from priority
A61B 5/0537A61B 5/4878A61B 5/4343A61B 5/4881A61B 5/4842A61B 5/443G01R 27/2605A61B 5/0531A61B 5/445A61B 5/4875A61B 5/6828
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides apparatuses and methods for measuring sub-epidermal moisture to provide clinicians with information related to physical conditions and ailments associated with accumulation or depletion of extracellular fluid.
Claims
exact text as granted — not AI-modified1 .- 4 . (canceled)
5 . A method for detecting preeclampsia in a patient, said method comprising:
measuring sub-epidermal moisture (SEM) values using a SEM scanner, wherein the SEM scanner comprises one or more sensors and a processor, wherein the one or more sensors are configured to measure an electrical property of the local tissue of the patient; obtaining a first SEM value at a first location; obtaining a second SEM value at a second location, wherein said first location and said second location are corresponding locations on a patient's body; and determining that said patient has preeclampsia when said first SEM value and said second SEM value are both above a predetermined threshold and are also within a predetermined range of each other.
6 .- 13 . (canceled)
14 . A method for detecting compartment syndrome at a first location of a patient's skin, the method comprising:
measuring sub-epidermal moisture (SEM) values using a SEM scanner, wherein the SEM scanner comprises one or more sensors and a processor, wherein the one or more sensors are configured to measure an electrical property of the local tissue of the patient's skin; obtaining a first SEM value at said first location, wherein said first location is located in a first compartment of the patient's body; obtaining a second SEM value at a second location of the patient's skin, wherein said second location is located in a second compartment of the patient's body; and determining whether the difference between said first SEM value and said second SEM value exceeds a predetermined amount indicative of compartment syndrome.
15 . The method of claim 14 , wherein said first and second locations are symmetric with respect to a centerline of the patient's body.
16 . The method of claim 14 , wherein said first SEM value exceeding said second SEM value by said predetermined amount is indicative of compartment syndrome at said first location.
17 . The method of claim 14 , wherein said second SEM value exceeding said first SEM value by said predetermined amount is indicative of compartment syndrome at said second location.
18 . The method of claim 14 , wherein said first SEM value corresponds to a level of extracellular fluid (ECF) at said first location of the patient's skin, and wherein said second SEM value corresponds to a level of ECF at said second location of the patient's skin.
19 . The method of claim 14 , wherein said first compartment is a forearm compartment in one arm and said second compartment is the corresponding forearm compartment in the other arm.
20 . The method of claim 14 , wherein said first compartment is a calf compartment in one leg and said second compartment is the corresponding calf compartment in the other leg.
21 . The method of claim 14 , wherein said first compartment is an osteofascial compartment in one hand and said second compartment is the corresponding osteofascial compartment in the other hand.
22 . The method of claim 14 , wherein said first and second SEM values are converted from capacitance measurements.
23 . The method of claim 14 , wherein said one or more sensors are selected from the group consisting of bipolar radio frequency (RF) sensors, virtual sensors, and toroidal bioimpedance sensors.
24 . The method of claim 5 , wherein said first SEM value corresponds to a level of extracellular fluid (ECF) at said first location on the patient's body, and wherein said second SEM value corresponds to a level of ECF at said second location on the patient's body.
25 . The method of claim 5 , wherein said first and second locations are symmetric with respect to a centerline of the patient's body.
26 . The method of claim 5 , wherein said first and second SEM values are converted from capacitance measurements.
27 . The method of claim 5 , wherein said one or more sensors are selected from the group consisting of bipolar RF sensors, virtual sensors, and toroidal bioimpedance sensors.Join the waitlist — get patent alerts
Track US2022273238A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.